C94.82
Other specified leukemias, in relapse
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code C94.82 refers to a specific type of leukemia that has recurred after treatment, known as leukemia in relapse. Leukemia is a type of cancer that affects the blood and bone marrow, characterized by the uncontrolled proliferation of abnormal white blood cells. When leukemia relapses, it means that after a period of remission—when symptoms diminish or disappear—cancer cells have returned or increased again. This condition requires careful medical assessment to determine the best course of action.
Causes & Symptoms
Clinical Causes: Previous incomplete treatment or resistance of leukemia cells to therapy Genetic mutations leading to the re-emergence of cancer cells Progression of the initial leukemia despite initial responses Environmental factors, such as exposure to certain chemicals or radiation Underlying genetic predispositions that favor recurrence
Key Symptoms: Fever or chills that persist or recur Unexplained weight loss or appetite changes Bone or joint pain Enlarged lymph nodes, liver, or spleen Persistent fatigue or weakness Frequent infections or easy bruising
Diagnostic & Treatment
Diagnosis Path: - Clinical evaluation: Reviewing patient history, previous treatments, and current symptoms.
Treatment Protocols: - Supportive care: Managing symptoms, preventing infections, and maintaining overall health during treatment.
Clinical Advice & FAQs
Billing Guidance
Is C94.82 a billable ICD-10 code?
Yes, C94.82 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C94.82?
Clinical documentation must specify the nature of Other specified leukemias, in relapse and any associated comorbidities for accurate reporting.
Cite this Clinical Reference